πŸ‡ΊπŸ‡Έ FDA
Patent

US 9309325

Antibodies and methods of use thereof

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 9309325 (Antibodies and methods of use thereof) held by The Regents of the University of California expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K38/00, A61K51/1075, A61P